13F 机构持仓

Davern Capital Partners, LP

NY NY · SEC CIK 0002003147

2026Q22026Q1 更早 9 个季度 🔒
$3.65亿2026Q1 申报市值
17持仓数
80.7%前十大占比 · 第一大 12.3%
4 / 1新建仓 / 清仓
申报市值走势$5.87亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

PFE 12.3%
REGN 9.5%
INSM 8.2%
IONS 8.0%
NTRA 7.9%
BNTX 7.4%
ARGX 7.0%
LLY 6.9%
RPRX 6.8%
ROIV 6.6%

2026Q1 买入最多 按季末市值估算

INSM 新建仓+$2,985.25万
LLY 加仓+$1,744.99万
NTRA 加仓+$1,306.25万
IONS 加仓+$1,114.53万
GENB 新建仓+$739.75万

2026Q1 卖出最多 按季末市值估算

RPRX 减仓-$1,538.11万
PFE 减仓-$1,258.83万
CGON 清仓-$672.64万
REGN 减仓-$588.75万
BNTX 减仓-$588.04万

2026Q1 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
CGON CG ONCOLOGY INC $00.00%0 -162,005-100.0% -$672.64万 清仓
VRDN VIRIDIAN THERAPEUTICS INC $591.61万1.62%302,457 40,84215.6% $79.89万 加仓
GPCR STRUCTURE THERAPEUTICS INC $609.54万1.67%126,461 126,461— $609.54万 新建仓
PRCT PROCEPT BIOROBOTICS CORP $653.26万1.79%261,200 261,200— $653.26万 新建仓
GENB GENERATE BIOMEDICINES INC $739.75万2.03%591,800 591,800— $739.75万 新建仓
ABVX ABIVAX SA $869.92万2.39%78,125 29,62361.1% $329.85万 加仓
MLYS MINERALYS THERAPEUTICS INC $1,211.34万3.32%447,153 236,505112.3% $640.69万 加仓
LEGN LEGEND BIOTECH CORP $2,378.38万6.52%1,314,748 258,08024.4% $466.87万 加仓
ROIV ROIVANT SCIENCES LTD $2,419.31万6.64%873,398 -154,900-15.1% -$429.07万 减仓
RPRX ROYALTY PHARMA PLC $2,494.48万6.84%520,009 -320,641-38.1% -$1,538.11万 减仓
LLY ELI LILLY & CO $2,509.04万6.88%27,279 18,972228.4% $1,744.99万 加仓
ARGX ARGENX SE $2,559.16万7.02%35,045 -640-1.8% -$46.74万 减仓
BNTX BIONTECH SE $2,711.33万7.44%305,055 -66,161-17.8% -$588.04万 减仓
NTRA NATERA INC $2,879.18万7.90%143,966 65,31683.0% $1,306.25万 加仓
IONS IONIS PHARMACEUTICALS INC $2,905.25万7.97%386,903 148,42662.2% $1,114.53万 加仓
INSM INSMED INC $2,985.25万8.19%182,562 182,562— $2,985.25万 新建仓
REGN REGENERON PHARMACEUTICALS $3,461.43万9.50%44,800 -7,620-14.5% -$588.75万 减仓
PFE PFIZER INC $4,475.79万12.28%1,593,942 -448,300-22.0% -$1,258.83万 减仓